Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
August 4, 2015
New Genome-Wide Methods for Elucidation of Candidate Copy Number Variations (CNVs) Contributing to Alzheimer's Disease Heritability
Kinga Szigeti
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Kinga Szigeti
European Journal of Human Genetics : EJHG
|
March 12, 2009
Charcot-Marie-Tooth disease
Kinga Szigeti, James R Lupski
Alzheimer'S Research & Therapy
|
June 3, 2011
Should persons with autosomal dominant AD be included in clinical trials? Authors' response
Kinga Szigeti, Rachelle S Doody
Alzheimer'S Research & Therapy
|
February 25, 2011
Should EOAD patients be included in clinical trials?
Kinga Szigeti, Rachelle S Doody
CNS Drugs
|
March 30, 2022
Role of Pharmacogenomics in Individualizing Treatment for Alzheimer's Disease
Natalie Argueta, Emily Notari, Kinga Szigeti
Neuromolecular Medicine
|
June 16, 2006
Molecular diagnostics of Charcot-Marie-Tooth disease and related peripheral neuropathies
Kinga Szigeti, Eva Nelis, James R Lupski
Frontiers in Genetics
|
June 18, 2026
The effect of human-specific genetic variants on neuronal spinogenesis
Nicolás Matías Rosas, Anna Szombathy, Kinga Szigeti
International Journal of Molecular Sciences
|
December 23, 2020
iPSC-Derived Microglia for Modeling Human-Specific DAMP and PAMP Responses in the Context of Alzheimer's Disease
Ivanna Ihnatovych, Barbara Birkaya, Emily Notari, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
February 17, 2006
Charcot-Marie-Tooth disease and related hereditary polyneuropathies: molecular diagnostics determine aspects of medical management
Kinga Szigeti, Carlos A Garcia, James R Lupski
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Methods in Molecular Biology (Clifton, N.J.)
|
August 4, 2015
New Genome-Wide Methods for Elucidation of Candidate Copy Number Variations (CNVs) Contributing to Alzheimer's Disease Heritability
Kinga Szigeti
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Kinga Szigeti
European Journal of Human Genetics : EJHG
|
March 12, 2009
Charcot-Marie-Tooth disease
Kinga Szigeti, James R Lupski
Alzheimer'S Research & Therapy
|
June 3, 2011
Should persons with autosomal dominant AD be included in clinical trials? Authors' response
Kinga Szigeti, Rachelle S Doody
Alzheimer'S Research & Therapy
|
February 25, 2011
Should EOAD patients be included in clinical trials?
Kinga Szigeti, Rachelle S Doody
CNS Drugs
|
March 30, 2022
Role of Pharmacogenomics in Individualizing Treatment for Alzheimer's Disease
Natalie Argueta, Emily Notari, Kinga Szigeti
Neuromolecular Medicine
|
June 16, 2006
Molecular diagnostics of Charcot-Marie-Tooth disease and related peripheral neuropathies
Kinga Szigeti, Eva Nelis, James R Lupski
Frontiers in Genetics
|
June 18, 2026
The effect of human-specific genetic variants on neuronal spinogenesis
Nicolás Matías Rosas, Anna Szombathy, Kinga Szigeti
International Journal of Molecular Sciences
|
December 23, 2020
iPSC-Derived Microglia for Modeling Human-Specific DAMP and PAMP Responses in the Context of Alzheimer's Disease
Ivanna Ihnatovych, Barbara Birkaya, Emily Notari, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
February 17, 2006
Charcot-Marie-Tooth disease and related hereditary polyneuropathies: molecular diagnostics determine aspects of medical management
Kinga Szigeti, Carlos A Garcia, James R Lupski
Page
of 5